Van Overtvelt L - Search Results

1

Bifidobacterium bifidum NCC 453 promotes tolerance induction in murine models of sublingual immunotherapy.

Moussu H, Van Overtvelt L, Horiot S, Tourdot S, Airouche S, Zuercher A, Holvoet S, Prioult G, Nutten S, Mercenier A, Mascarell L, Moingeon P. Moussu H, et al. Among authors: van overtvelt l. Int Arch Allergy Immunol. 2012;158(1):35-42. doi: 10.1159/000330101. Epub 2011 Dec 28. Int Arch Allergy Immunol. 2012. PMID: 22205338

2

Novel ways for immune intervention in immunotherapy: mucosal allergy vaccines.

Mascarell L, Van Overtvelt L, Moingeon P. Mascarell L, et al. Among authors: van overtvelt l. Immunol Allergy Clin North Am. 2006 May;26(2):283-306, vii-viii. doi: 10.1016/j.iac.2006.02.009. Immunol Allergy Clin North Am. 2006. PMID: 16701145 Review.

3

Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation.

Razafindratsita A, Saint-Lu N, Mascarell L, Berjont N, Bardon T, Betbeder D, Van Overtvelt L, Moingeon P. Razafindratsita A, et al. Among authors: van overtvelt l. J Allergy Clin Immunol. 2007 Aug;120(2):278-85. doi: 10.1016/j.jaci.2007.04.009. Epub 2007 May 25. J Allergy Clin Immunol. 2007. PMID: 17531296

4

IL-10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model.

Van Overtvelt L, Lombardi V, Razafindratsita A, Saint-Lu N, Horiot S, Moussu H, Mascarell L, Moingeon P. Van Overtvelt L, et al. Int Arch Allergy Immunol. 2008;145(2):152-62. doi: 10.1159/000108140. Epub 2007 Sep 11. Int Arch Allergy Immunol. 2008. PMID: 17848808

5

A synthetic triacylated pseudo-dipeptide molecule promotes Th1/TReg immune responses and enhances tolerance induction via the sublingual route.

Mascarell L, Van Overtvelt L, Lombardi V, Razafindratsita A, Moussu H, Horiot S, Chabre H, Limal D, Moutel S, Bauer J, Chiavaroli C, Moingeon P. Mascarell L, et al. Among authors: van overtvelt l. Vaccine. 2007 Dec 21;26(1):108-18. doi: 10.1016/j.vaccine.2007.10.050. Epub 2007 Nov 9. Vaccine. 2007. PMID: 18063445

6

Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells.

Mascarell L, Lombardi V, Louise A, Saint-Lu N, Chabre H, Moussu H, Betbeder D, Balazuc AM, Van Overtvelt L, Moingeon P. Mascarell L, et al. Among authors: van overtvelt l. J Allergy Clin Immunol. 2008 Sep;122(3):603-9.e5. doi: 10.1016/j.jaci.2008.06.034. J Allergy Clin Immunol. 2008. PMID: 18774396

7

Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.

Lombardi V, Van Overtvelt L, Horiot S, Moingeon P. Lombardi V, et al. Among authors: van overtvelt l. J Immunol. 2009 Mar 15;182(6):3372-9. doi: 10.4049/jimmunol.0801969. J Immunol. 2009. PMID: 19265114

8

Lactic acid bacteria as adjuvants for sublingual allergy vaccines.

Van Overtvelt L, Moussu H, Horiot S, Samson S, Lombardi V, Mascarell L, van de Moer A, Bourdet-Sicard R, Moingeon P. Van Overtvelt L, et al. Vaccine. 2010 Apr 9;28(17):2986-92. doi: 10.1016/j.vaccine.2010.02.009. Epub 2010 Feb 20. Vaccine. 2010. PMID: 20175969

9

Induction of allergen-specific tolerance via mucosal routes.

Mascarell L, Zimmer A, Van Overtvelt L, Tourdot S, Moingeon P. Mascarell L, et al. Among authors: van overtvelt l. Curr Top Microbiol Immunol. 2011;352:85-105. doi: 10.1007/82_2011_132. Curr Top Microbiol Immunol. 2011. PMID: 21562971 Review.

10

Immune mechanisms of allergen-specific sublingual immunotherapy.

Moingeon P, Batard T, Fadel R, Frati F, Sieber J, Van Overtvelt L. Moingeon P, et al. Among authors: van overtvelt l. Allergy. 2006 Feb;61(2):151-65. doi: 10.1111/j.1398-9995.2006.01002.x. Allergy. 2006. PMID: 16409190 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page